eBook: Breakthroughs in oncology research and drug discovery

Cancer cells

While the age-adjusted overall cancer death rate in the US fell by 33% between 1991 and 2020, cancer remains a significant threat to human health, with more than two million new cases expected to be diagnosed in 2024 and uneven progress across different cancer types1.

These figures demonstrate that the development of highly effective targeted therapeutics and immunotherapies is more important than ever, despite the astonishing rate of progress.

In the last few years, immunotherapies like immune checkpoint inhibitors, vaccines and cell and gene therapies have revolutionised the treatment of cancer, and targeted drugs like monoclonal antibodies (mAbs), poly-ADP ribose polymerase (PARP) inhibitors and targeted protein degraders are also playing an important role.

This 24-page eBook sponsored by Sino Biological explores the latest innovations in cancer therapeutics and where we can expect the greatest breakthroughs in the future.

Download this exclusive eBook to learn more about:

  • The opportunities and advances in cancer research
  • Why liquid biopsies are important in precision medicine trials for cancer
  • How genetic tuning willtransform the reach for CAR-T therapies
  • The latest developments in breast cancer therapy

References

  1. https://cancerprogressreport.aacr.org/progress/

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free